Icon
+91 94997 68112
Login Register

ORTIKOS - ()

BUDESONIDE None
Less Than $1000 mn
None None
None None
None None
None
No
ORTIKOS Patent 1 Patent 2
*** *********

ORTIKOS - (6MG, 9MG)

BUDESONIDE None
6MG, 9MG
Less Than $1000 mn
None None
None None
None None
ORTIKOS is a corticosteroid indicated for: • Treatment of mild to moderate active Crohn’s disease involving the ileum and/or the ascending colon, in patients 8 years and older. • Maintenance of clinical remission of mild to moderate Crohn’s disease involving the ileum and/or the ascending colon for up to 3 months in adults.
Yes
ORTIKOS Patent 1 Patent 2
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.